Chris Katje
Ives Ultra AI Opportunities
IVAI · NYSE
$10.11+$0.03 (+0.30%)TodayMarket closed ·
Prev close $10.08
IVAI key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 371.29K
- Volume
- 371.34K
- Open price
- $10.08
- High today
- $10.13
- Low today
- $10.08
- 52 Week high
- $10.32
- 52 Week low
- $10.05
Ives Ultra AI Opportunities (IVAI) at a glance
Ives Ultra AI Opportunities (IVAI) last traded at $10.11, with a price-to-earnings ratio of 0.00.
Today the stock has traded between $10.08 and $10.13. The current price is 0.3% above the day's low and 0.2% below its high.
Volume so far is 371.34K shares, in line with the average of 371.29K shares a day.
Over the past year Ives Ultra AI Opportunities has ranged from $10.05 to $10.32, and now sits 22% of the way up that range.
IVAI news
- Press releasePRNewswire
Ives Ultra AI Opportunities Inc. (NYSE: IVAI) Announces Pricing of $200 Million Initial Public Offering
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.